EGFR and posterior cortical atrophy: Restoration of CMTM5-v1 leads to inhibition of EGFR tyrosine kinase activity, which implies that the sensitivity of PCa cells to EGFR TKIs, such as Gefitinib, may be increased by CMTM5.